Meaning
A formal regulatory approval issued by a competition authority confirms that a proposed merger or acquisition does not violate competition laws or restrict market rivalry. Securing antitrust clearance is a standard condition precedent in international share purchase agreements, where the transaction cannot proceed to completion until the relevant watchdogs grant their consent. The process ensures that large corporate consolidations do not create dominant positions that could harm consumers through higher prices or reduced output.
In many jurisdictions, this evaluation is mandatory, meaning that the parties are legally prohibited from executing their deal until the formal decision is delivered.
Regulatory Threshold
Filing requirements depend on specific financial triggers, such as the worldwide or regional revenue of the transacting entities. Once these thresholds are met, the transaction cannot close until antitrust clearance has been obtained. The parties must submit detailed information regarding their market shares, major competitors and supply chains to allow for a detailed analysis of the transaction’s impact.
Review Period
The investigation proceeds in phases, starting with a preliminary assessment that typically lasts around thirty days. If the regulatory body identifies potential competition concerns, it will initiate a second, more detailed phase that can extend the wait by several months. During this second phase, the transacting entities may need to offer structural remedies, such as divestures, to obtain antitrust clearance.
Transaction Closure
No transfer of ownership or control can occur while the regulatory evaluation is ongoing. Initiating any integration activities before obtaining antitrust clearance constitutes a violation of competition laws, which can lead to severe financial penalties. The transaction agreement will typically include a drop-dead date, allowing either party to terminate the deal if the regulatory approval is not secured within a specified timeframe.
